Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA3 | P07451 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | BRD2 | P25440 | 1/20 | 0.35 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9387072 | 0.87 | GAA (0.50) | LMNAGAAKMT2A | |
| SCHEMBL26079396 | 0.87 | GAA (0.50) | LMNAGAAKMT2A | |
| SCHEMBL27547194 | 0.86 | GAA (0.49) | LMNAGAAKMT2A | |
| SCHEMBL1982542 | 0.86 | GAA (0.49) | LMNAGAAKMT2A | |
| SCHEMBL6886372 | 0.86 | LMNA (0.41) | LMNACA12CA1CA2CA3 | |
| SCHEMBL8481372 | 0.84 | LMNA (0.43) | LMNACA12CA1CA2CA3 | |
| SCHEMBL8162071 | 0.84 | GAA (0.44) | LMNAALDH1A1GAAKMT2AMEN1 | |
| SCHEMBL11045299 | 0.83 | GAA (0.49) | GAAKMT2AMEN1 | |
| SCHEMBL8104688 | 0.82 | LMNA (0.40) | LMNACA12CA1CA2CA3 | |
| SCHEMBL23813764 | 0.82 | LMNA (0.39) | LMNACA12CA1CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005561-A | Preparation and application of ionizable lipid molecules of benzaldehyde framework | 浙江工业大学 | 2024-05-10 | — | — | CN | disclosed |
| CN-115845812-B | Preparation method and application of magnetic lignin adsorption material | 大连工业大学 | 2024-05-03 | — | — | CN | disclosed |
| CN-217068857-U | Synthesis equipment of piracetam | 赤峰万泽药业股份有限公司 | 2022-07-29 | — | — | CN | disclosed |
| US-20110223318-A1 | METHOD FOR INTRODUCING FUNCTIONAL GROUP TO SURFACE OF MATERIAL | KANGNUNG-WONJU NATIONAL UNIVERSITY INDUSTRY ACADEMY COOPERATION GROUP (KR) | 2011-09-15 | — | — | US | disclosed |
| EP-2354146-A1 | METHOD FOR INTRODUCING FUNCTIONAL GROUP TO SURFACE OF MATERIAL | Kangnung-Wonju National University Industry Academy Cooperation Group (KR) | 2011-08-10 | — | — | EP | disclosed |
| US-7157421-B2 | Piracetam and piracetam analog conjugate and a pharmaceutical composition for treatment of neuronal disorders | MILLER LANDON C G | 2007-01-02 | — | — | US | disclosed |
| US-20060142182-A1 | Piracetam and piracetam analog conjugate and a pharmaceutical composition for treatment of neuronal disorders | MILLER LANDON C | 2006-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060142182-A1 | Piracetam and piracetam analog conjugate and a pharmaceutical composition for treatment of neuronal disorders | PRLHR, GIPR, NTSR1 | LMNA 2073/4885CA12 833/4885CA1 673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.